Gala Therapeutics Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Employees
  • 39

Employees
  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $100M

  • Investors
  • 1

Gala Therapeutics General Information

Description

Developer of disease-modifying therapies designed to improve survival, quality of life, and outcomes for patients with lung cancer, COPD (Chronic Obstructive Pulmonary Disease), asthma, and other pulmonary diseases. The company's system offers a single-use catheter and electrosurgical generator to deliver non-thermal energy to the airways to reduce mucus-producing cells in patients, enabling physicians to treat their patients better, resulting in a better medical outcome.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 1531 Industrial Road
  • Suite 100
  • San Carlos, CA 94070
  • United States
+1 (650) 000-0000

Gala Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gala Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 29-Mar-2022 $100M 00000 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 18-Nov-2019 000.00 000.00 000.00 Completed Generating Revenue
To view Gala Therapeutics’s complete valuation and funding history, request access »

Gala Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Gala Therapeutics’s complete cap table history, request access »

Gala Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of disease-modifying therapies designed to improve survival, quality of life, and outcomes for patients with l
Therapeutic Devices
San Carlos, CA
39 As of 2021
00000
0000 0000-00-00
00000000000 00000

000000

isi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit es
00000000000 0000000
Lexington, MA
00 As of 0000
00000
00000000000 00000

000000

ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
00000 0000000 000 00000000
Redwood City, CA
000 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gala Therapeutics Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RejuvenAir Venture Capital-Backed Lexington, MA 00 00000 00000000000 00000
0000000 Formerly VC-backed Redwood City, CA 000 00000 00000000 00000
0000000 Venture Capital-Backed Minneapolis, MN 00 00000 0000000000 0 00000
You’re viewing 3 of 3 competitors. Get the full list »

Gala Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Kevin Taylor Chief Operating Officer
Deborah Sheffield Senior Vice President of Regulatory & Quality Affairs
Jonathan Waldstreicher MD Founder, Chief Executive Officer, President & Board Member
James Stambaugh Senior Vice President, Clinical Affairs & Strategy
To view Gala Therapeutics’s complete executive team members history, request access »

Gala Therapeutics Board Members (5)

Name Representing Role Since
Douglas Godshall Self Co-Chairman 000 0000
Jonathan Waldstreicher MD Self Founder, Chief Executive Officer, President & Board Member 000 0000
Seth Harrison MD Self Co-Chairman 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Gala Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gala Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ATP (Apple Tree Partners) Venture Capital Minority 000 0000 000000 0
To view Gala Therapeutics’s complete investors history, request access »